MiR-15a and miR-16-1 cluster functions in human leukemia

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  2008-04-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/pnas.0800121105PMID 18362358PMCID PMC2278188
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• mir-29 regulates Mcl-1 protein expression and apoptosis

  2007cited by this paper
• Investigation of microRNA alterations in leukemias and lymphomas.

  2007cited by this paper
• Regulatory mechanisms of microRNAs involvement in cancer

  2007cited by this paper
• Transcripts Targeted by the MicroRNA-16 Family Cooperatively Regulate Cell Cycle Progression

  2007cited by this paper
• MicroRNA control of Nodal signalling

  2007cited by this paper
• Repression of protein synthesis by miRNAs: how many mechanisms?

  2007cited by this paper
• Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice.

  2007cited by this paper
• Mcl-1 Is a Relevant Therapeutic Target in Acute and Chronic Lymphoid Malignancies: Down-Regulation Enhances Rituximab-Mediated Apoptosis and Complement-Dependent Cytotoxicity

  2007cited by this paper
• MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

  2007cited by this paper
• Oncomirs — microRNAs with a role in cancer

  2006cited by this paper
• Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181.

  2006cited by this paper
• Identification and analysis of microRNAs.

  2006cited by this paper
• Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance.

  2006cited by this paper
• MicroRNA expression and function in cancer.

  2006cited by this paper
• Cyclin E but not bcl-2, bax or mcl-1 is differentially expressed in ZAP 70-positive and ZAP 70-negative B-CLL cells

  2006cited by this paper
• A genome-wide map of conserved microRNA targets in C. elegans.

  2006influential reference
• A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia.

  2005influential reference
• miR-15 and miR-16 induce apoptosis by targeting BCL2.

  2005influential reference
• Systematic discovery of regulatory motifs in human promoters and 3′ UTRs by comparison of several mammals

  2005cited by this paper
• Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs

  2005cited by this paper
• Prediction and Analysis of Human microRNA Regulatory Modules

  2005cited by this paper
• Involvement of a cell adhesion molecule, TSLC1/IGSF4, in human oncogenesis

  2005cited by this paper
• ARED 3.0: the large and diverse AU-rich transcriptome

  2005cited by this paper
• Real-time quantification of microRNAs by stem–loop RT–PCR

  2005cited by this paper
• Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.

  2005cited by this paper
• Involvement of microRNA in AU-rich element-mediated mRNA instability.

  2005cited by this paper
• MicroRNAs: a developing story.

  2005cited by this paper
• Specificity of microRNA target selection in translational repression.

  2004cited by this paper
• Intensified Cloning Efforts Have Revealed Numer

  2004cited by this paper
• 21.10 n&v 915 MH

  2004cited by this paper
• Prognostic significance of a short sequence insertion in the MCL-1 promoter in chronic lymphocytic leukemia.

  2004cited by this paper
• Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.

  2004cited by this paper
• Overexpression of a cell adhesion molecule, TSLC1, as a possible molecular marker for acute-type adult T-cell leukemia.

  2004cited by this paper
• Role of Myeloid Cell Factor-1 (Mcl-1) in Chronic Lymphocytic Leukemia

  2004cited by this paper
• MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias.

  2004cited by this paper
• Definition and diagnosis of sporadic and familial chronic lymphocytic leukemia.

  2004cited by this paper
• A combined computational-experimental approach predicts human microRNA targets.

  2004cited by this paper
• Cell cycle deregulation in B-cell lymphomas.

  2003cited by this paper
• Prediction of mammalian microRNA targets.

  2003cited by this paper
• Expression profiling reveals off-target gene regulation by RNAi

  2003cited by this paper
• Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia

  2002cited by this paper
• A System for Stable Expression of Short Interfering RNAs in Mammalian Cells

  2002cited by this paper
• TSLC1 is a tumor-suppressor gene in human non-small-cell lung cancer

  2001cited by this paper
• ARED: human AU-rich element-containing mRNA database reveals an unexpectedly diverse functional repertoire of encoded proteins

  2001cited by this paper
• Expression of apoptosis-regulating proteins in chronic lymphocytic leukemia: correlations with In vitro and In vivo chemoresponses.

  1998cited by this paper

• Therapeutic microRNAs: Mechanisms, Delivery, and Clinical Translation in Oncology

  2026cites this paper
• Putative Prognostic Value of miR-15a and miR-221 in Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma

  2026cites this paper
• Nanotechnology-driven heart targeting to fulfil the potential of cardiac microRNA therapies.

  2026cites this paper
• СУЧАСНІ ПІДХОДИ ДО ДІАГНОСТИКИ ТА ПРОГНОЗУВАННЯ ПЕРЕБІГУ ХРОНІЧНОГО ЛІМФОЛЕЙКОЗУ

  2025cites this paper
• MYH9: Structure, functions, and therapeutic implications in cancer and genetic disorders

  2025cites this paper
• Androgen Receptor‐Controlled microRNA‐124‐3p.2 Suppresses Prostate Cancer Progression via CCL2 Inhibition

  2025cites this paper
• Role of the TLR signaling pathway in the pathogenesis of glioblastoma multiforme with an emphasis on immunotherapy

  2025cites this paper
• Plasma exosomal miR-122-5p_R-1, miR-23b-3p_R + 1, and miR-15a-5p_R-1 are associated with multidrug-resistant tuberculosis

  2025cites this paper
• miR-126: a bridge between cancer and exercise

  2025cites this paper
• The Heterogeneity of 13q Deletions in Chronic Lymphocytic Leukemia: Diagnostic Challenges and Clinical Implications

  2025cites this paper
• Exosomal biomarkers in leukemia: translational potential and regulatory challenges for precision medicine applications

  2025cites this paper
• Role of microRNAs in hematological malignancies research: A bibliometric analysis

  2025cites this paper
• The intersection of ferroptosis and non-coding RNAs: a novel approach to ovarian cancer

  2025cites this paper
• Quercetin-Mediated Modulation of Tumor Suppressor miR-15a, miR-34a, and p53 Signaling in MCF-7 Breast Cancer Cells

  2025cites this paper
• Extracellular Vesicle microRNAs in the Crosstalk Between Cancer Cells and Natural Killer (NK) Cells

  2025cites this paper
• Non-coding RNA modulation in osteoclasts and its implications for osteoblast lineage cell behavior in a co-culture system

  2025cites this paper
• PDCD4: A critical regulator in leukemic signaling networks and its therapeutic potential

  2025cites this paper
• Ferroptosis and ovarian cancer: a bibliometric study and visualization analysis

  2025cites this paper
• MicroRNA Profiling as a Predictive Indicator for Time to First Treatment in Chronic Lymphocytic Leukemia: Insights from the O-CLL1 Prospective Study

  2024cites this paper
• Multifaceted Landscape ofOmics Data

  2024cites this paper
• Tumor antigen presentation and the associated signal transduction during carcinogenesis.

  2024cites this paper
• Innovations and developments in chronic lymphocytic leukemia therapy

  2024cites this paper
• The Potential Role of microRNAs in the Progression and Aggressiveness of Gallbladder Cancer: Molecular Markers to Therapeutic Interventions

  2024cites this paper
• miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia

  2024cites this paper
• The role of lncRNA and miRNA on the effects of occurrence and development of osteosarcoma.

  2024cites this paper
• Metalloproteomic Analysis of Hemophilic Arthropathy Synovial Tissue: Insights into Metal Overload and Pathogenesis.

  2024cites this paper
• Ferroptosis contributes to the progression of female-specific neoplasms, from breast cancer to gynecological malignancies in a manner regulated by non-coding RNAs: Mechanistic implications

  2024cites this paper
• How MicroRNAs Command the Battle against Cancer

  2024cites this paper
• Elucidating gastric cancer mechanisms and therapeutic potential of Adociaquinone A targeting EGFR: A genomic analysis and Computer Aided Drug Design (CADD) approach

  2024cites this paper
• RNA kinetics influence the response to transcriptional perturbation in leukaemia cell lines

  2024cites this paper
• Non-Coding RNA-Targeted Therapy: A State-of-the-Art Review

  2024cites this paper
• MiR-4492, a New Potential MicroRNA for Cancer Diagnosis and Treatment: A Mini Review

  2024cites this paper
• Role of transcription factors, noncoding RNAs, epitranscriptomics, and epigenetics in post‐ischemic neuroinflammation

  2024cites this paper
• Viable mutations of mouse midnolin suppress B cell malignancies

  2024cites this paper
• The DLEU2/miR-15a/miR-16-1 cluster shapes the immune microenvironment of chronic lymphocytic leukemia

  2024cites this paper
• CMC: Cancer miRNA Census – a list of cancer-related miRNA genes

  2024cites this paper
• The Killer’s Web: Interconnection between Inflammation, Epigenetics and Nutrition in Cancer

  2024cites this paper
• Dysregulated MicroRNAs in Chronic Lymphocytic Leukemia

  2024cites this paper
• Chemokine Ligands and Receptors Regulate Macrophage Polarization in Atherosclerosis: A Comprehensive Database Mining Study

  2024cites this paper
• Multiple omics levels of chronic lymphocytic leukemia

  2024cites this paper
• Analysis of Primary Chronic Lymphocytic Leukemia Cells’ Signaling Pathways

  2024cites this paper
• Msx1‐Modified Rat Bone Marrow Mesenchymal Stem Cell Therapy for Rotator Cuff Repair: A Comprehensive Analysis of Tendon‐Bone Healing and Cellular Mechanisms

  2024cites this paper
• BCL2 Protein Progressively Declines during Robust CLL Clonal Expansion: Potential Impact on Venetoclax Clinical Efficacy and Insights on Mechanism

  2024cites this paper
• Potential therapies for non-coding RNAs in breast cancer

  2024cites this paper
• In Vivo Screening Unveils Pervasive RNA-Binding Protein Dependencies in Leukemic Stem Cells and Identifies ELAVL1 as a Therapeutic Target

  2023cites this paper
• Machine learning in the development of targeting microRNAs in human disease

  2023cites this paper
• DNA hypermethylation-induced miR-182 silence targets BCL2 and HOXA9 to facilitate the self-renewal of leukemia stem cell, accelerate acute myeloid leukemia progression, and determine the sensitivity of BCL2 inhibitor venetoclax

  2023cites this paper
• Modulating epigenetic modifications for cancer therapy (Review)

  2023cites this paper
• Synthetic RNA Therapeutics in Cancer

  2023cites this paper
• Role of microRNAs in Chronic Lymphocytic Leukemia

  2023cites this paper
• A glance into the roles of microRNAs (exosomal and non-exosomal) in polycystic ovary syndrome

  2023cites this paper
• Non-coding RNAs in disease: from mechanisms to therapeutics

  2023cites this paper
• A novel ferroptosis-related microRNA signature with prognostic value in osteosarcoma

  2023cites this paper
• Complete miRNA-15/16 loss in mice promotes hematopoietic progenitor expansion and a myeloid-biased hyperproliferative state

  2023influential citation
• microRNA sequencing for biomarker detection in the diagnosis, classification and prognosis of Diffuse Large B Cell Lymphoma

  2023cites this paper
• The role of noncoding RNAs in metabolic reprogramming of cancer cells

  2023influential citation
• Hepatitis B Virus Modulated Transcriptional Regulatory Map of Hepatic Cellular MicroRNAs

  2023cites this paper
• Preclinical investigations of the efficacy of the glutaminase inhibitor CB-839 alone and in combinations in chronic lymphocytic leukemia

  2023cites this paper
• Shared Molecular Pathways in Glaucoma and Other Neurodegenerative Diseases: Insights from RNA-Seq Analysis and miRNA Regulation for Promising Therapeutic Avenues

  2023cites this paper
• microRNAs and Other Non-Coding RNAs as Targets for Anticancer Drug Development

  2023cites this paper
• An Overview of the Role of MicroRNAs on Carcinogenesis: A Focus on Cell Cycle, Angiogenesis and Metastasis

  2023cites this paper
• Small Non-Coding RNAs in Soft-Tissue Sarcomas: State of the Art and Future Directions.

  2023cites this paper
• miR-6893-3p is a bonafide negative regulator of splicing activator, RNPS1

  2023cites this paper
• Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update

  2023cites this paper
• Intracellular Compartmentalization: A Key Determinant of MicroRNA Functions.

  2023cites this paper
• miRNA-Based Technologies in Cancer Therapy

  2023cites this paper
• Characterization of proteins, mRNAs, and miRNAs of circulating extracellular vesicles from prostate cancer patients compared to healthy subjects

  2022cites this paper
• Anti‐hsa‐miR‐59 alleviates premature senescence associated with Hutchinson‐Gilford progeria syndrome in mice

  2022cites this paper
• Dynamic interplay of microRNA in diseases and therapeutic

  2022cites this paper
• Quercetin potentiates 5-fluorouracil effects in human colon cancer cells through targeting the Wnt/β-catenin signalling pathway: the role of miR-27a

  2022cites this paper
• A review on the role of mir-16-5p in the carcinogenesis

  2022cites this paper
• Innovative approaches in transforming microRNAs into therapeutic tools

  2022cites this paper
• MicroRNAs as Regulators of Cancer Cell Energy Metabolism

  2022cites this paper
• MiRNA-16-1 Suppresses Mcl-1 and Bcl-2 and Sensitizes Chronic Lymphocytic Leukemia Cells to BH3 Mimetic ABT-199

  2022cites this paper
• Potential therapeutic applications of microRNAs in cancer diagnosis and treatment: Sharpening a double-edged sword?

  2022cites this paper
• Analysis of ROQUIN, Tristetraprolin (TTP), and BDNF/miR-16/TTP regulatory axis in late onset Alzheimer’s disease

  2022cites this paper
• miRacle of microRNA-Driven Cancer Nanotherapeutics

  2022cites this paper
• miRNA therapeutics in precision oncology: a natural premium to nurture

  2022cites this paper
• MiR-146b-5p regulates IL-23 receptor complex expression in chronic lymphocytic leukemia cells

  2022cites this paper
• Microfluidic assisted recognition of miRNAs towards point-of-care diagnosis: Technical and analytical overview towards biosensing of short stranded single non-coding oligonucleotides.

  2022cites this paper
• Effect of Diet Enriched With Hemp Seeds on Goat Milk Fatty Acids, Transcriptome, and miRNAs

  2022cites this paper
• miRNA in Molecular Diagnostics

  2022cites this paper
• Micro-RNAs in Response to Active Forms of Vitamin D3 in Human Leukemia and Lymphoma Cells

  2022cites this paper
• Microfluidics for detection of exosomes and microRNAs in cancer: State of the art

  2022cites this paper
• Non-coding RNAs and ferroptosis: potential implications for cancer therapy

  2022cites this paper
• MicroRNA-101-3p Suppresses Cancer Cell Growth by Inhibiting the USP47-Induced Deubiquitination of RPL11

  2022cites this paper
• Non-coding RNAs as emerging regulators and biomarkers in colorectal cancer

  2022cites this paper
• MicroRNAs in Leukemias: A Clinically Annotated Compendium

  2022cites this paper
• Small Non-Coding RNAs in Leukemia

  2022cites this paper
• Evaluation of miR-15a, miR-16-1, ZAP-70, Ang-2, and Bcl-2 as potential prognostic biomarkers in chronic lymphocytic leukemia

  2022cites this paper
• Oxidative Stress-Mediated miRNA Regulation in Cancer

  2022cites this paper
• MicroRNAs as Modulators of the Immune Response in T-Cell Acute Lymphoblastic Leukemia

  2022cites this paper
• Epigenetic Small-Molecule Modulators Targeting Metabolic Pathways in Cancer.

  2022cites this paper
• MiR-6165 Dysregulation in Breast Cancer and Its Effect on Cell Proliferation and Migration

  2021cites this paper
• Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial

  2021cites this paper
• Integrated mRNA and miRNA Transcriptomic Analyses Reveals Divergent Mechanisms of Sunitinib Resistance in Clear Cell Renal Cell Carcinoma (ccRCC)

  2021cites this paper
• Effective tools for RNA-derived therapeutics: siRNA interference or miRNA mimicry

  2021cites this paper
• MiRNA-Mediated Knock-Down of Bcl-2 and Mcl-1 Increases Fludarabine-Sensitivity in CLL-CII Cells

  2021cites this paper
• Alterations in The Plasma Expression of mir-15b, mir-195 and the Tumor-Suppressor Gene DLEU7 in Patients with B-Cell Chronic Lymphocytic Leukemia.

  2021cites this paper
• FLUORESCENCE IN SITU HYBRIDIZATION ANALYSIS Interphase Fluorescence in Situ hybridization Analysis of 17p13.1 and 11q22.3 Deletions among CLL Patients

  2021cites this paper